Biolexis Therapeutics to Present Two Groundbreaking Abstracts at Upcoming Scientific Conference

AMERICAN FORK, Utah, June 21, 2024 /PRNewswire/ — Biolexis, a pioneering biopharmaceutical company, is proud to announce the presentation of two significant abstracts at the upcoming American Diabetes Association conference on June 21-24, 2024. The abstracts, titled “Discovery of a…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks